23andMe is a privately held biotechnology company that is developing new ways to help people make sense of their own genetic information. Google has invested $3.9M in the company.  Genentech is also reported to have invested in 23andMe.
Thomas Söderqvist wrote:
There has not been much news about the company yet (see Blaine Bettinger’s blog The Genetic Geneaologist and Attila Csordas’ Pimm), but my guess is that we will hear more about it in the near future. Whatever its future prospects, however, it’s already a good example of how converging technologies ... are emerging at the start-up company level.
The marriage between Sergey Brin and Anne Wojcicki is thus not just a romantic Silicon Valley story; it’s also today’s counterpart to traditional politically motivated marital alliances and gives a new meaning to the concept of converging technologies.
Kevin Kelleher in GigaOM writes: " A case could be made that there is a good reason for Google to make this deal. And although I realize I may end up regretting it, I am going to make that case.... an investment in 23andMe lets Google chart yet another collision coarse [sic] with Microsoft’s ambitions. ... If Google wants to really organize the world information, it needs to consider DNA, the most personal of data. And what 23andMe is purporting to sell is the ultimate in navel gazing."
- "Google invests in genetics firm". BBC. Retrieved 2007-06-28.
- Kevin Kelleher (May 24, 2007). "Google, Sergey and 23andMe: Why it all makes sense". GigaOmniMedia. Retrieved 2007-06-27. Check date values in:
- Nick Denton (May 14 2007). "Sergey Brin and Anne Wojcicki". Valleywag. Retrieved 2007-06-27. Check date values in:
- Hafner, Kate (May 29, 2007), "Silicon Valley Wide-Eyed Over a Bride", The New York Times, retrieved 2007-06-28 Check date values in:
- Thomas Söderqvist (20 May 2007). "23andMe and converging technologies". Medical Museion. University of Copenhagen. Retrieved 2007-06-27. Check date values in: